299 related articles for article (PubMed ID: 25689610)
21. Plant-based vaccines against viruses.
Rybicki EP
Virol J; 2014 Dec; 11():205. PubMed ID: 25465382
[TBL] [Abstract][Full Text] [Related]
22. Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines.
Rey FA; Lok SM
Cell; 2018 Mar; 172(6):1319-1334. PubMed ID: 29522750
[TBL] [Abstract][Full Text] [Related]
23. A Focus on Veterinary Immunology.
Woodland DL
Viral Immunol; 2015 Nov; 28(9):477. PubMed ID: 26535450
[No Abstract] [Full Text] [Related]
24. Editorial overview: Viral immunology.
Dittmer D; Damania B
Curr Opin Virol; 2020 Oct; 44():v-vi. PubMed ID: 33349419
[No Abstract] [Full Text] [Related]
25. Viral vectors for use in the development of biodefense vaccines.
Lee JS; Hadjipanayis AG; Parker MD
Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
[TBL] [Abstract][Full Text] [Related]
26. [Problems and concepts of active immunologic prevention of human virus diseases].
Kańtoch M
Przegl Epidemiol; 1985; 39(3-4):354-62. PubMed ID: 3832169
[No Abstract] [Full Text] [Related]
27. Specific immunoprophylaxis of some viral diseases in cattle.
Rola J; Polak MP; Zmudziński JF
Pol J Vet Sci; 2005; 8(4):315-21. PubMed ID: 16385857
[TBL] [Abstract][Full Text] [Related]
28. Antibodies, viruses and vaccines.
Burton DR
Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139
[TBL] [Abstract][Full Text] [Related]
29. Novel vaccine strategies against emerging viruses.
García-Sastre A; Mena I
Curr Opin Virol; 2013 Apr; 3(2):210-6. PubMed ID: 23477832
[TBL] [Abstract][Full Text] [Related]
30. Viral strategies for evading antiviral cellular immune responses of the host.
Iannello A; Debbeche O; Martin E; Attalah LH; Samarani S; Ahmad A
J Leukoc Biol; 2006 Jan; 79(1):16-35. PubMed ID: 16204622
[TBL] [Abstract][Full Text] [Related]
31. [Progess in the development of VLPs vaccine].
Cao L; Bi SL
Bing Du Xue Bao; 2011 Jul; 27(4):378-82. PubMed ID: 21874909
[No Abstract] [Full Text] [Related]
32. Editorial overview: Viral pathogenesis.
Guidotti LG; Iannacone M
Curr Opin Virol; 2015 Apr; 11():v-vii. PubMed ID: 25795138
[No Abstract] [Full Text] [Related]
33. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.
Delrue I; Verzele D; Madder A; Nauwynck HJ
Expert Rev Vaccines; 2012 Jun; 11(6):695-719. PubMed ID: 22873127
[TBL] [Abstract][Full Text] [Related]
34. Review of companion animal viral diseases and immunoprophylaxis.
Patel JR; Heldens JG
Vaccine; 2009 Jan; 27(4):491-504. PubMed ID: 19041354
[TBL] [Abstract][Full Text] [Related]
35. [Progress in virus-like particles technique studies].
Guo JQ; Zhang ZQ
Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):167-73. PubMed ID: 20077665
[TBL] [Abstract][Full Text] [Related]
36. Wanted, dead or alive: new viral vaccines.
Amanna IJ; Slifka MK
Antiviral Res; 2009 Nov; 84(2):119-30. PubMed ID: 19733596
[TBL] [Abstract][Full Text] [Related]
37. Letter from the editor.
Ellis R; Weiss AC
Hum Vaccin Immunother; 2015; 11(3):533. PubMed ID: 25839215
[No Abstract] [Full Text] [Related]
38. [Anemia in broilers--development of a vaccine for breeder stock].
Vielitz E; von Bülow V; Landgraf H; Conrad C
Zentralbl Veterinarmed B; 1987 Oct; 34(8):553-7. PubMed ID: 3124413
[No Abstract] [Full Text] [Related]
39. [Progress in developing viral polynucleotide (DNA) vaccines].
Gendon IuZ
Vopr Virusol; 1999; 44(4):148-54. PubMed ID: 10500980
[TBL] [Abstract][Full Text] [Related]
40. Viral vaccines: selected topics.
Kańtoch M
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):367-71. PubMed ID: 9017153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
